No slowing down: Regulator says blood clots, allergies no concern in vaccine rollout

Thursday March 18, 2021

Australia’s medicines regulator says there are no specific problems around either of the two COVID-19 vaccines, as GPs gear up for the next phase of the rollout.

The Therapeutic Goods Administration says it has received 19 reports of anaphylaxis – a form of allergic reaction – nationally, 14 of which followed the Pfizer vaccine and five followed the AstraZeneca vaccine.

As of March 15, the TGA had not received any reports of blood clots following the use of the AstraZeneca vaccine, which at least 17 countries are currently investigating while suspending…

Click here to view the original article.